Description
Products
8 productsBiosimilar to Humira. Late preclinical.
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Prolia/Xgeva. Preclinical (process scale-up).
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Opdivo. Late preclinical.
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Synagis. Preclinical (process scale-up).
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Keytruda. Preclinical (process scale-up).
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Perjeta. Preclinical (process scale-up).
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Herceptin. Phase 1 (2018).
Under development
Finished product (FDF)
Verified on 2026-10-21
Biosimilar to Stelara. Phase 1 (2019).
Under development
Finished product (FDF)
Verified on 2026-10-21